Malaysia Lipid Market Size & Outlook, 2022-2030
Malaysia lipid market, 2018-2030 (US$M)
Related Markets
Malaysia lipid market highlights
- The Malaysia lipid market generated a revenue of USD 275.3 million in 2022 and is expected to reach USD 474.8 million by 2030.
- The Malaysia market is expected to grow at a CAGR of 7.1% from 2023 to 2030.
- In terms of segment, clinical was the largest revenue generating phase in 2022.
- Clinical is the most lucrative phase segment registering the fastest growth during the forecast period.
Lipid market data book summary
| Market revenue in 2022 | USD 275.3 million |
| Market revenue in 2030 | USD 474.8 million |
| Growth rate | 7.1% (CAGR from 2022 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Clinical |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clinical, Pre-clinical |
| Key market players worldwide | Danaher Corp, Evonik Industries AG, Merck KGaA, Croda International PLC, Lipoid, Cargill, Basf SE, Archer-Daniels Midland Co, Koninklijke DSM NV, Kerry Group PLC Class A, Nordic Naturals, Fiserv Inc, Omega Protein |
Other key industry trends
- In terms of revenue, Malaysia accounted for 2.9% of the global lipid market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China lipid market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 989.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Lipid Market Scope
Lipid Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Malaysia lipid market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lipid market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 18.45% in 2022. Horizon Databook has segmented the Malaysia lipid market based on clinical, pre-clinical covering the revenue growth of each sub-segment from 2018 to 2030.
According to the Malaysian Investment Development Authority (MIDA), Malaysia has the potential to become a global manufacturing hub of vaccines for covid-19 and other viruses in the future, due to the rising global requirement for vaccines for infections like COVID-19.
The government of Malaysia introduced a new tax relaxation in the budget 2022 to attract foreign investments in the country’s pharmaceutical industry. In addition, the prevailing COVID-19 situation and the risk of heart disease have escalated the demand for pharmaceutical products. This is expected to drive the demand for lipids from the pharmaceutical industry in Malaysia over the projected years.
Reasons to subscribe to Malaysia lipid market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Malaysia lipid market databook
-
Our clientele includes a mix of lipid market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Malaysia lipid market , including forecasts for subscribers. This country databook contains high-level insights into Malaysia lipid market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Malaysia lipid market size, by phase, 2018-2030 (US$M)
Malaysia Lipid Market Outlook Share, 2022 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
